Phenotype‐Dependent Effect of Bedtime Antihypertensive Dosing on Nocturnal Blood Pressure: A Meta‐Analysis Guided by Non‐Dipper Prevalence
The Journal of Clinical Hypertension · 2026
DOI: 10.1111/jch.70331 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Journal of Clinical Hypertension, 2026. Verfasst von Min Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Antihypertensive Agents, Blood Pressure, Circadian Rhythm, Hypertension. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Natural Science Foundation.
Abstract (Originalsprache)
Bedtime dosing of antihypertensive medications is associated with a reduction in nocturnal blood pressure (BP), but whether this effect is modified at the study level remains uncertain. We conducted an updated meta‐analysis of randomized controlled trials comparing bedtime versus morning antihypertensive administration, evaluating the overall treatment effect and its potential modification by baseline non‐dipper prevalence. PubMed, EMBASE, and the Cochrane Library were searched, with nighttime ambulatory systolic BP (SBP) and diastolic BP (DBP) as primary outcomes. Subgroup analyses were performed based on baseline non‐dipper proportion (< 60% vs. ≥ 60%). Sixty‐six RCTs involving 29,654 participants were included. In the overall hypertensive population, bedtime dosing significantly reduced nighttime SBP (WMD: 4.87 mmHg; 95% CI: 3.75–6.00) and DBP (WMD: 2.80 mmHg; 95% CI: 2.23–3.37), with modest reductions in 24 h SBP (WMD: 2.06 mmHg) and daytime SBP (WMD: 0.99 mmHg). In trials restricted to non‐dippers, a more pronounced reduction in nighttime BP was observed (SBP WMD: 7.57 mmHg; DBP WMD: 3.77 mmHg). Similarly, study populations with a higher baseline proportion of non‐dippers (≥ 60%) experienced approximately two‐fold higher nighttime SBP reductions versus those with lower prevalence (< 60%) (WMD: ∼9.7 vs. 4.4 mmHg; p < 0.01), with a consistent pattern for nighttime DBP (5.1 vs. 2.6 mmHg; between‐group p < 0.05). Bedtime antihypertensive dosing reduces nocturnal BP across the general hypertensive population; however, the magnitude of effect appears to be modified at the study level by baseline non‐dipper prevalence. These findings suggest that chronotherapy effects are heterogeneous across trial populations rather than uniform across all hypertensive individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Peking University First Hospital, Beijing, China.
- Institute of Cardiovascular Disease, Peking University First Hospital, Beijing, China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
- NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University, Beijing, China.
Förderung
- Beijing Natural Science Foundation
Zitieren
APA
Li, M., Zhou, Z., Fan, F., Ma, W., Li, J., & Zhang, Y. (2026). Phenotype‐Dependent Effect of Bedtime Antihypertensive Dosing on Nocturnal Blood Pressure: A Meta‐Analysis Guided by Non‐Dipper Prevalence. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70331
Vancouver
Li M, Zhou Z, Fan F, Ma W, Li J, Zhang Y. Phenotype‐Dependent Effect of Bedtime Antihypertensive Dosing on Nocturnal Blood Pressure: A Meta‐Analysis Guided by Non‐Dipper Prevalence. The Journal of Clinical Hypertension. 2026. doi:10.1111/jch.70331
BibTeX
@article{Li2026,
author = {Li, Min and Zhou, Zuoyi and Fan, Fangfang and Ma, Wei and Li, Jianping and Zhang, Yan},
title = {Phenotype‐Dependent Effect of Bedtime Antihypertensive Dosing on Nocturnal Blood Pressure: A Meta‐Analysis Guided by Non‐Dipper Prevalence},
journal = {The Journal of Clinical Hypertension},
year = {2026},
doi = {10.1111/jch.70331}
}
EUVIMED